Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES - Patent Acquisitions (Details Narrative)

COMMITMENTS AND CONTINGENCIES - Patent Acquisitions (Details Narrative)	1 Months Ended	59 Months Ended
	Dec. 29, 2017 USD ($) Agreement	Mar. 31, 2018 USD ($)	Jun. 03, 2014 USD ($)	May 21, 2013 USD ($) $ / shares shares	Feb. 28, 2013 USD ($) shares
Acquisition of Cox patents cash, purchase price					$ 1,000,000
Acquisition of Cox patents, common stock issued \| shares					403,226
Obligated to pay Cox, net proceeds percentage					12.50%
Capitalized professional fees and filing fees related to M2M Patent Portfolio	$ 250,000
Capitalized professional fees and filing fees related to Cox Patent Portfolio					$ 169,000
Cash consideration for Mirror Worlds patent acquisition				$ 3,000,000
Cost of repurchase of Mirror Worlds warrants			$ 505,000
Issued 5-year warrants (Looking Glass) to purchase shares of common stock \| shares				1,750,000
5-year warrants (Looking Glass) to purchase 875,000 shares, exercise price per share \| shares				1.40
5-year warrants (Looking Glass) to purchase 875,000 shares, exercise price per share \| shares				2.10
Capitalized professional fees and filing fees related to Mirror Worlds patents				$ 409,000
Net proceeds percentage payable to Recognition from the monetization of the Mirror Worlds patent portfolio
First $125 Million				10.00%
Next $125 Million				15.00%
Over $250 Million				20.00%
Recognition paid related to Mirror Worlds patents		$ 3,127,000
First warrants to purchase an aggregate of 1,250,000 shares of common stock \| shares				500,000
First warrants to purchase an aggregate of 1,250,000 shares of common stock, exercise price per share \| $ / shares				$ 2.05
Second warrants to purchase an aggregate of 1,250,000 shares of common stock \| shares				375,000
Second warrants to purchase an aggregate of 1,250,000 shares of common stock, exercise price per shares \| $ / shares				$ 2.10
Third warrants to purchase an aggregate of 1,250,000 shares of common stock \| shares				375,000
Third warrants to purchase an aggregate of 1,250,000 shares of common stock, exercise price per shares \| $ / shares				$ 1.40
Proceeds from exercise of warrants				$ 2,337,500
Obligation to pay M2M for acquisation
Amount of professional fillings fees capitalized as patented cost	$ 88,000
First $100	14.00%
Next $100	5.00%
Additional consideration payable upon occurrence of certain future events	$ 250,000
Payment to acquire the M2M/IoT Patent Portfolio	$ 1,000,000
Description of additional consideration to payable	Obligation to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from Monetization Activities (as defined) related to the patent portfolio
M2M [ Member]
Obligation to pay M2M for acquisation
Number of U.S. patents acquired \| Agreement	12